Found 4 hits for monomerid = 50007241 Target/Host (Institution) | Ligand | Target/Host Links | Ligand Links | Trg + Lig Links | Ki nM | ΔG° kcal/mole | IC50 nM | Kd nM | EC50/IC50 nM | koff s-1 | kon M-1s-1 | pH | Temp °C |
Glucagon receptor
(Homo sapiens (Human)) | BDBM50007241
(CHEMBL3238229)Show SMILES CC(C)[C@H]1CC[C@]2(CC1)N=C(C(=O)N2[C@H](CCC(C)(C)C)c1ccc(cc1)C(=O)NCc1nn[nH]n1)c1cc(Cl)cc(Cl)c1 |r,wU:14.16,3.2,wD:6.5,c:10,(22.68,-7.09,;24,-7.87,;23.99,-9.41,;25.34,-7.11,;25.6,-5.59,;27.05,-5.06,;28.24,-6.05,;27.98,-7.57,;26.53,-8.1,;28.65,-4.57,;30.2,-4.51,;30.73,-5.96,;32.21,-6.37,;29.52,-6.91,;29.57,-8.44,;28.25,-9.23,;28.27,-10.77,;26.94,-11.56,;26.96,-13.1,;25.6,-10.8,;25.6,-12.31,;30.9,-9.23,;30.87,-10.78,;32.2,-11.56,;33.55,-10.81,;33.57,-9.27,;32.24,-8.48,;34.87,-11.6,;34.85,-13.14,;36.21,-10.85,;37.53,-11.63,;38.88,-10.88,;40.27,-11.51,;41.32,-10.38,;40.56,-9.04,;39.05,-9.34,;30.97,-3.18,;30.21,-1.85,;30.99,-.51,;30.22,.83,;32.53,-.52,;33.29,-1.86,;34.83,-1.87,;32.52,-3.19,)| Show InChI InChI=1S/C33H41Cl2N7O2/c1-20(2)21-10-14-33(15-11-21)37-29(24-16-25(34)18-26(35)17-24)31(44)42(33)27(12-13-32(3,4)5)22-6-8-23(9-7-22)30(43)36-19-28-38-40-41-39-28/h6-9,16-18,20-21,27H,10-15,19H2,1-5H3,(H,36,43)(H,38,39,40,41)/t21-,27-,33-/m1/s1 | PDB MMDB
UniProtKB/SwissProt
B.MOAD antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Patents
Similars
| Article PubMed
| n/a | n/a | 31 | n/a | n/a | n/a | n/a | n/a | n/a |
Merck Research Laboratories
Curated by ChEMBL
| Assay Description Displacement of [125I]-glucagon from recombinant human GCGR expressed in CHO cells after 60 mins by scintillation counting analysis |
J Med Chem 57: 2601-10 (2014)
Article DOI: 10.1021/jm401858f BindingDB Entry DOI: 10.7270/Q20V8F9P |
More data for this Ligand-Target Pair | |
Glucagon-like peptide 1 receptor
(Homo sapiens (Human)) | BDBM50007241
(CHEMBL3238229)Show SMILES CC(C)[C@H]1CC[C@]2(CC1)N=C(C(=O)N2[C@H](CCC(C)(C)C)c1ccc(cc1)C(=O)NCc1nn[nH]n1)c1cc(Cl)cc(Cl)c1 |r,wU:14.16,3.2,wD:6.5,c:10,(22.68,-7.09,;24,-7.87,;23.99,-9.41,;25.34,-7.11,;25.6,-5.59,;27.05,-5.06,;28.24,-6.05,;27.98,-7.57,;26.53,-8.1,;28.65,-4.57,;30.2,-4.51,;30.73,-5.96,;32.21,-6.37,;29.52,-6.91,;29.57,-8.44,;28.25,-9.23,;28.27,-10.77,;26.94,-11.56,;26.96,-13.1,;25.6,-10.8,;25.6,-12.31,;30.9,-9.23,;30.87,-10.78,;32.2,-11.56,;33.55,-10.81,;33.57,-9.27,;32.24,-8.48,;34.87,-11.6,;34.85,-13.14,;36.21,-10.85,;37.53,-11.63,;38.88,-10.88,;40.27,-11.51,;41.32,-10.38,;40.56,-9.04,;39.05,-9.34,;30.97,-3.18,;30.21,-1.85,;30.99,-.51,;30.22,.83,;32.53,-.52,;33.29,-1.86,;34.83,-1.87,;32.52,-3.19,)| Show InChI InChI=1S/C33H41Cl2N7O2/c1-20(2)21-10-14-33(15-11-21)37-29(24-16-25(34)18-26(35)17-24)31(44)42(33)27(12-13-32(3,4)5)22-6-8-23(9-7-22)30(43)36-19-28-38-40-41-39-28/h6-9,16-18,20-21,27H,10-15,19H2,1-5H3,(H,36,43)(H,38,39,40,41)/t21-,27-,33-/m1/s1 | PDB
UniProtKB/SwissProt
antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Patents
Similars
| Article PubMed
| n/a | n/a | >1.00E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
Merck Research Laboratories
Curated by ChEMBL
| Assay Description Antagonist activity at human GLP-1R expressed in CHO cells assessed as inhibition of GLP-1-stimulated cAMP production preincubated for 30 mins follow... |
J Med Chem 57: 2601-10 (2014)
Article DOI: 10.1021/jm401858f BindingDB Entry DOI: 10.7270/Q20V8F9P |
More data for this Ligand-Target Pair | |
Glucagon receptor
(Homo sapiens (Human)) | BDBM50007241
(CHEMBL3238229)Show SMILES CC(C)[C@H]1CC[C@]2(CC1)N=C(C(=O)N2[C@H](CCC(C)(C)C)c1ccc(cc1)C(=O)NCc1nn[nH]n1)c1cc(Cl)cc(Cl)c1 |r,wU:14.16,3.2,wD:6.5,c:10,(22.68,-7.09,;24,-7.87,;23.99,-9.41,;25.34,-7.11,;25.6,-5.59,;27.05,-5.06,;28.24,-6.05,;27.98,-7.57,;26.53,-8.1,;28.65,-4.57,;30.2,-4.51,;30.73,-5.96,;32.21,-6.37,;29.52,-6.91,;29.57,-8.44,;28.25,-9.23,;28.27,-10.77,;26.94,-11.56,;26.96,-13.1,;25.6,-10.8,;25.6,-12.31,;30.9,-9.23,;30.87,-10.78,;32.2,-11.56,;33.55,-10.81,;33.57,-9.27,;32.24,-8.48,;34.87,-11.6,;34.85,-13.14,;36.21,-10.85,;37.53,-11.63,;38.88,-10.88,;40.27,-11.51,;41.32,-10.38,;40.56,-9.04,;39.05,-9.34,;30.97,-3.18,;30.21,-1.85,;30.99,-.51,;30.22,.83,;32.53,-.52,;33.29,-1.86,;34.83,-1.87,;32.52,-3.19,)| Show InChI InChI=1S/C33H41Cl2N7O2/c1-20(2)21-10-14-33(15-11-21)37-29(24-16-25(34)18-26(35)17-24)31(44)42(33)27(12-13-32(3,4)5)22-6-8-23(9-7-22)30(43)36-19-28-38-40-41-39-28/h6-9,16-18,20-21,27H,10-15,19H2,1-5H3,(H,36,43)(H,38,39,40,41)/t21-,27-,33-/m1/s1 | PDB MMDB
UniProtKB/SwissProt
B.MOAD antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Patents
Similars
| Article PubMed
| n/a | n/a | 52 | n/a | n/a | n/a | n/a | n/a | n/a |
Merck Research Laboratories
Curated by ChEMBL
| Assay Description Antagonist activity at human GCGR expressed in CHO cells assessed as inhibition of glucagon-stimulated cAMP production preincubated for 30 mins follo... |
J Med Chem 57: 2601-10 (2014)
Article DOI: 10.1021/jm401858f BindingDB Entry DOI: 10.7270/Q20V8F9P |
More data for this Ligand-Target Pair | |
Glucagon receptor
(Mus musculus) | BDBM50007241
(CHEMBL3238229)Show SMILES CC(C)[C@H]1CC[C@]2(CC1)N=C(C(=O)N2[C@H](CCC(C)(C)C)c1ccc(cc1)C(=O)NCc1nn[nH]n1)c1cc(Cl)cc(Cl)c1 |r,wU:14.16,3.2,wD:6.5,c:10,(22.68,-7.09,;24,-7.87,;23.99,-9.41,;25.34,-7.11,;25.6,-5.59,;27.05,-5.06,;28.24,-6.05,;27.98,-7.57,;26.53,-8.1,;28.65,-4.57,;30.2,-4.51,;30.73,-5.96,;32.21,-6.37,;29.52,-6.91,;29.57,-8.44,;28.25,-9.23,;28.27,-10.77,;26.94,-11.56,;26.96,-13.1,;25.6,-10.8,;25.6,-12.31,;30.9,-9.23,;30.87,-10.78,;32.2,-11.56,;33.55,-10.81,;33.57,-9.27,;32.24,-8.48,;34.87,-11.6,;34.85,-13.14,;36.21,-10.85,;37.53,-11.63,;38.88,-10.88,;40.27,-11.51,;41.32,-10.38,;40.56,-9.04,;39.05,-9.34,;30.97,-3.18,;30.21,-1.85,;30.99,-.51,;30.22,.83,;32.53,-.52,;33.29,-1.86,;34.83,-1.87,;32.52,-3.19,)| Show InChI InChI=1S/C33H41Cl2N7O2/c1-20(2)21-10-14-33(15-11-21)37-29(24-16-25(34)18-26(35)17-24)31(44)42(33)27(12-13-32(3,4)5)22-6-8-23(9-7-22)30(43)36-19-28-38-40-41-39-28/h6-9,16-18,20-21,27H,10-15,19H2,1-5H3,(H,36,43)(H,38,39,40,41)/t21-,27-,33-/m1/s1 | PDB
KEGG
UniProtKB/SwissProt
B.MOAD GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Patents
Similars
| Article PubMed
| n/a | n/a | 200 | n/a | n/a | n/a | n/a | n/a | n/a |
Merck Research Laboratories
Curated by ChEMBL
| Assay Description Displacement of [125I]-glucagon from GCGR in mouse liver membranes after 60 mins by scintillation counting analysis |
J Med Chem 57: 2601-10 (2014)
Article DOI: 10.1021/jm401858f BindingDB Entry DOI: 10.7270/Q20V8F9P |
More data for this Ligand-Target Pair | |